Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
about
Neutrophils in Cancer: Two Sides of the Same CoinImmunoglobulin A: magic bullet or Trojan horse?Neutrophils in cancer.Progress in tumor-associated macrophage (TAM)-targeted therapeutics.Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo.
P2860
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
@en
type
label
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
@en
prefLabel
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
@en
P2093
P50
P1476
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
@en
P2093
Arianne M Brandsma
Geert van Tetering
Gerard Rouwendal
István Németh
J H Marco Jansen
Laura A P M Meulenbroek
M Alejandra Beltrán Buitrago
Maaike Nederend
Peter Boross
Ruud Ubink
P304
P356
10.1158/2326-6066.CIR-15-0099-T
P577
2015-09-25T00:00:00Z